- Country: Japan
- Summary: Support for Holding the 5Th Early New Drug Development Trial Translational Research Workshop
- JPT Ref No: 81669212
- Deadline: 28 Apr 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.:
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Support for holding the 5th Early New Drug Development Trial Translational Research Workshop - Explanatory text : Support for holding the 5th Early New Drug Development Trial Translational Research Workshop - The following is open to competition.
Hitoshi Nakagama, President, National Cancer Center - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSupport for Holding the 5Th Early New Drug Development Trial Translational Research Workshop - Japan Tender
The NATIONAL CANCER CENTER JAPAN, a Government sector organization in Japan, has announced a new tender for Support for Holding the 5Th Early New Drug Development Trial Translational Research Workshop. This tender is published on JapanTenders under JPT Ref No: 81669212 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-04-28.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
